Sabar Karimah Es bought CAPR
March 31, 2026 · Form 4 insider transaction
Sabar Karimah Es bought 61,265 shares of Capricor Therapeutics, Inc. at $4.86 per share, a transaction worth $297.7K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
61,265
Price
$4.86
Total value
$297.7K
InsiderSabar Karimah Es
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 31, 2026
Filing dateApril 1, 2026
Shares owned after61,265
OwnershipDirect
10b5-1 planNo
AmendedNo